Unique ID issued by UMIN | UMIN000002888 |
---|---|
Receipt number | R000003511 |
Scientific Title | Efficacy of BCAA food additional intake added to dosage of medicine made of BCAA |
Date of disclosure of the study information | 2009/12/14 |
Last modified on | 2020/03/31 17:37:42 |
Efficacy of BCAA food additional intake added to dosage of medicine made of BCAA
Efficacy of BCAA food addition intake in BCAA replenishment treatment
Efficacy of BCAA food additional intake added to dosage of medicine made of BCAA
Efficacy of BCAA food addition intake in BCAA replenishment treatment
Japan |
decompensated cirrhosis
Hepato-biliary-pancreatic medicine |
Others
NO
The effectiveness of the BCAA food addition intake in the BCAA substitution therapy to serum BTR and serum albumin is examined
Safety,Efficacy
Confirmatory
Pragmatic
Phase III
Serum BTR (branched chain amino acids / tyrosine molar ratio) and serum albumin revel after 12 weeks from the beginning of the dairy branched-chain amino acid supplementation intake
Quality of Life(SF-36) and Urinary 8-OHdG(8-Hydroxydeoxyguanosine) excretion after 12 weeks from the beginning of the dairy branched-chain amino acid supplementation intake
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Food |
Medicine made of BCAA granules (4.0g) is taken 12 weeks continuously three times a day.
In addition, the BCAA supplementation (3.2g) is taken as late evening snack every day.
Medicine made of BCAA granules (4.0g) is taken 12 weeks continuously three times a day.
Not applicable |
Not applicable |
Male and Female
1. Decompensated cirrhosis
2. The dietary intake is possible.
3. Hypoalbuminemia
4. Patients who give documentary informed consent voluntarily
5. Patient who fills all of the above-mentioned 1-4
1. Patient who doesn't belong to application object of LIVACT
2. Patient who has the past of hepatic encephalopathy
3. Patient who has allergy in element of AMINOFEEL
4. The dietary intake is not enough in anorexia etc. , and the serum albumin is patients who decreased 0.1mg/dL or more in the past two months.
5. Patient who has infectious disease that becomes problem in clinical
6. Patient with serious glucose intolerance, respiratory failure and renal failure
7. Patient inappropriate for participating to this study decided by the attending physicians
50
1st name | Shuhei |
Middle name | |
Last name | Nishiguchi |
Hyogo College of Medicine
Division of Hepatobiliary and Pancreatic Diseases
663-8501
1-1 Mukogawa, Nishinomiya, Hyogo, JAPAN
0798-45-6472
nishiguc@hyo-med.ac.jp
1st name | Masaki |
Middle name | |
Last name | Saito |
Hyogo College of Medicine
Division of Hepatobiliary and Pancreatic Diseases
663-8501
1-1 Mukogawa, Nishinomiya, Hyogo, JAPAN
0798-45-6472
he-jishu@hyo-med.ac.jp
Hyogo College of Medicine
Hyogo College of Medicine
Self funding
Japan
Hyogo College of Medicine
Mukogawa-cho 1-1, Mishinomiya, Hyogo
0798-45-6154
shomu@hyo-med.ac.jp
NO
2009 | Year | 12 | Month | 14 | Day |
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000003511
Unpublished
No publication
0
No entry
2020 | Year | 03 | Month | 31 | Day |
No entry
No entry
No entry
No entry
Terminated
2009 | Year | 09 | Month | 01 | Day |
2009 | Year | 10 | Month | 15 | Day |
2009 | Year | 11 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 06 | Month | 01 | Day |
2009 | Year | 12 | Month | 14 | Day |
2020 | Year | 03 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003511